Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV

Briot, 2001, Dose–volume histogram analysis for tumour and critical organs in intracavitary brachytherapy of cervical cancer with the use of MRI. Annual Brachytherapy Meeting GEC/ESTRO, Radiother Oncol, 60, S3, 10.1016/S0167-8140(01)80014-1

Burghardt, 1989, Magnetic resonance imaging in cervical cancer: a basis for objective classification, Gynecol Oncol, 33, 61, 10.1016/0090-8258(89)90604-5

Cetingoz, 2001, Optimisation in high dose-rate brachytherapy for utero-vaginal applications, Radiother Oncol, 58, 31, 10.1016/S0167-8140(00)00295-4

Dimopoulos, 2004, Systematic evaluation of MRI and clinical findings in cervical cancer at diagnosis and at time of brachytherapy: potential of MRI on delineation of GTV, patho-anatomical structures and organs at risk, Radiother Oncol, 71, S9, 10.1016/S0167-8140(04)80071-9

Dimopoulos, 2004, Combined MRI-based intracavitary and interstitial brachytherapy for locally advanced cervical cancer with a modified tandem ring applicator-clinical feasibility and preliminary results, Radiother Oncol, 71, S10, 10.1016/S0167-8140(04)80074-4

Erickson, 2003, The sculpted pear: an unfinished brachytherapy tale, Brachytherapy, 2, 189, 10.1016/j.brachy.2003.09.001

Fellner, 2001, Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects, Radiother Oncol, 58, 53, 10.1016/S0167-8140(00)00282-6

Fromm, 2002, Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma, Radiother Oncol, 63, S4, 10.1016/S0167-8140(02)80019-6

Gerbaulet, 2002, Cervix cancer, 301

Gong, 1999, Determination of tumour regression rates during radiotherapy for cervical carcinoma by serial MRI: comparison of two measurement techniques and examination of intraobserver and interobserver variability, Br J Radiol, 72, 62, 10.1259/bjr.72.853.10341691

Haie-Meder, 2003, Curiethérapie dans les cancers du col utérin: évolution des techniques et des concepts, Cancer Radiother, 7, 42, 10.1016/S1278-3218(02)00282-2

Haie-Meder, 2000, Radiochimiothérapie concomitante dans les cancers du col utérin: modifications des standards, Cancer Radiother, 4, 134s, 10.1016/S1278-3218(00)88653-9

Hellebust, 2001, Inter fraction variations in rectum and bladder volumes and dose distributions during high dose-rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations, Radiother Oncol, 60, 273, 10.1016/S0167-8140(01)00386-3

ICRU, International Commission of Radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynaecology. ICRU Report 38, Bethesda, MD; 1985.

Kim, 1993, Preoperative staging of uterine cervical carcinoma: comparison of CT and MR in 99 patients, J Comput Assist Tomogr, 17, 633, 10.1097/00004728-199307000-00022

Kirisits, 2004, Dose parameters for MRI based treatment planning—analysis of 93 individual fractions in cervix cancer brachytherapy for 22 patients, Radiother Oncol, 71, S9, 10.1016/S0167-8140(04)80073-2

Lang, 2004, Intercomparison of treatment concepts for 3D image guided brachytherapy of cervical carcinoma based on a GEC ESTRO study protocol, Radiother Oncol, 71, S11, 10.1016/S0167-8140(04)80076-8

Lang, 2004, Combined MRI-based intracavitary and interstitial brachytherapy for locally advanced cervical cancer with a modified tandem ring applicator—design, quality assurance and dosimetry, Radiother Oncol, 71, S72, 10.1016/S0167-8140(04)80202-0

Mayr, 2002, Method and timing of tumour volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging, Int J Radiat Oncol Biol Phys, 52, 14, 10.1016/S0360-3016(01)01808-9

Mayr, 1997, Tumour size evaluated by pelvic examination compared with 3-D MR quantitative analysis in the prediction of outcome for cervical cancer, Int J Radiat Oncol Biol Phys, 39, 395, 10.1016/S0360-3016(97)00318-0

Nevinson, 2001, CT based brachytherapy planning and complimentary bioeffect dosimetry: evaluation of combined brachytherapy and external beam radiotherapy dose distributions, in the treatment of cervical cancer, Radiother Oncol, 60, S2, 10.1016/S0167-8140(01)80012-8

Orton, 1994, Radiobiology

Pötter, 1997, Modern imaging methods used for treatment planning and quality assurance for combined irradiation of cervix cancer, 23

Pötter, 2000, Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993–1997) compared to the preceding period in the context of ICRU 38 recommendations, Cancer Radiother, 4, 159, 10.1016/S1278-3218(00)88900-3

Pötter, 2001, Survey of the use of ICRU 38 in recording and reporting cervical cancer brachytherapy, Radiother Oncol, 58, 11, 10.1016/S0167-8140(00)00266-8

Pötter, 2002, Role of image based volume assessment (Vienna method), 115

Pötter, 2002, CT/MRI assisted brachytherapy in gynaecology, Radiother Oncol, 64, S20, 10.1016/S0167-8140(02)82384-2

Pötter, 2002, Vienna method, 331

Pötter, 2002, Reporting in brachytherapy: dose and volume specification, 155

Pötter, 2004, Reporting time-dose pattern in intracavitary brachytherapy: considerations on a common language using the linear-quadratic model, Radiother Oncol, 71, S38

Stitt, 1992, High dose-rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations, Int J Radiat Oncol Biol Phys, 1, 313

Subak, 1995, Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging (Review), Obstet Gynecol, 86, 43, 10.1016/0029-7844(95)00109-5

Tardivon, 1996, MR imaging during intracavitary brachytherapy of vaginal and cervical cancers: preliminary results, Radiographics, 16, 1363, 10.1148/radiographics.16.6.8946541

Wachter, 2001, The impact of MRI on the delineation of gross tumour volume in cervical cancer treatment planning: an interobserver analysis, Radiother Oncol, 60, S3, 10.1016/S0167-8140(01)80013-X

Wachter-Gerstner, 2003, The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of prospective comparative trial, Radiother Oncol, 68, 51, 10.1016/S0167-8140(03)00083-5

Wachter-Gerstner, 2003, Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point, Radiother Oncol, 68, 269, 10.1016/S0167-8140(03)00189-0